TITLE

Comparison of Sirolimus and Colchicine Treatment on the Development of Peritoneal Fibrozis in Rats Having Peritoneal Dialysis

AUTHOR(S)
Sağıroğlu, Tamer; Sayhan, Mustafa Burak; Yağcı, Mehmet A.; Yalta, Tülin; Sağıroğlu, Gönül; Çopuroğlu, Elif; Oğuz, Serhat
PUB. DATE
January 2015
SOURCE
Balkan Medical Journal;2015, Vol. 32 Issue 1, p101
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Continuous ambulatory peritoneal dialysis is a successful treatment modality for patients with end-stage renal disease. Peritoneal fibrosis (PF) is the most critical complication of long-term peritoneal dialysis (PD). Aims: In our study, we aimed to compare the effects of colchicine and sirolimus on PF induced by hypertonic peritoneal dialysis solutions in rats. Study Design: Animal experiment. Methods: Twenty-four rats were randomly divided into three groups. The control group received an intraperitoneal injection (ip) of saline. The sirolimus group received the PD solution, plus 1.0 mg/kg/day Rapamune ®. The colchicine group received the PD solution ip plus 1.0 mg/kg/day of colchicine. Blood samples were taken to measure the serum levels of VEGF, TGF-β, and TNF-α. Peritoneal tissue samples were taken for histopathological evaluation. Results: TGF-β and TNF-α values in the sirolimus group were found to be statistically significantly lower than in the control and colchicine groups, but the differences between the control and colchicine groups were not statistically significant. No statistically significant differences were found between the groups regarding the VEGF values. Vascular neogenesis and peritoneal thickness were compared; the values in the sirolimus group were statistically reduced compared to the values in the control group. Mild fibrosis developed in 75% of all animals in the sirolimus group; there was no moderate or severe fibrosis observed. Fibrosis developed to varying degrees in 100% of the animals in the control and colchicine groups. Conclusion: The present study demonstrates that sirolimus might be beneficial for preventing or delaying the progression of PF and neoangiogenesis. These alterations in the peritoneal membrane may be connected with reduced TNF-α and TGF-β levels.
ACCESSION #
110738002

 

Related Articles

  • Surgical Technique Using An Improvised Peritoneal Catheter In An Experimental Non-Uremic Rabbit Model Of Peritoneal Dialysis. Slobodan, Krstić; Jasna, Trbojević-Stanković; Snežana, Žunić; Nataša, Jovanović; Biljana, Stojimirović // Acta Veterinaria;Sep2015, Vol. 65 Issue 3, p319 

    Experimental models have strongly contributed to the comprehension of the processes of peritoneal damage that take place during peritoneal dialysis treatment in human patients. A variety of peritoneal dialysis models have been developed, mostly using rats and rabbits. In this study we present...

  • Supporting and Retaining Nephrology Nurses New to the Peritoneal Dialysis Specialty. Peters, April // Nephrology Nursing Journal;Jan/Feb2013, Vol. 40 Issue 1, p21 

    The use of home dialysis treatment modalities, including peritoneal dialysis, is increasing. To have a successful peritoneal dialysis program, organizations must recognize the special abilities required of the nurse practicing in the peritoneal dialysis specialty. This article identifies...

  • 腹膜透析并发包裹性腹膜硬化症1例报道. 张贺; 李振元; 严豪; 张敏芳; 王琴; 王玲; 倪兆慧; 钱家麒; 方炜 // Journal of Shanghai Jiaotong University (Medical Science);Nov2016, Vol. 36 Issue 11, p1682 

    Objective · To improve awareness, prevention, and treatment of peritoneal dialysis-related encapsulating peritoneal sclerosis. Methods · A case developing encapsulating peritoneal sclerosis after discontinuing peritoneal dialysis and receiving medication treatment was analyzed. Results...

  • Kronik Böbrek YetmezliÄŸi Olan Bir Hastada Sefoperazon/Sulbaktam Kullanımına BaÄŸlı GeliÅŸen Koagülopati : Olgu sunumu. Korkmaz, Ahmet Edip; Ünal, Aydın; Sipahioğlu, Murat Hayri; Korkmaz, Züleyha; Tokgöz, Bülent; Oymak, Oktay; Utaş, Cengiz // Erciyes Medical Journal / Erciyes Tip Dergisi;2010, Vol. 32 Issue 1, p45 

    Continuous ambulatory peritoneal dialysis is one of renal replacement treatment in patients with end-stage kidney disease. Peritonitis is a serious problem in peritoneal dialysis patients that leads to hospitalisation and increased mortality. In treatment of peritoneal dialysis- associated...

  • Morbidity outcomes by ESRD treatment modality. Foley, Robert N.; Murphy, Sean W. // Kidney International Supplement;Jan2000, Issue 74, pS-82 

    Examines the morbidity outcomes by end-stage renal disease (ESRD) treatment modality. Comparison between hemodialysis and peritoneal dialysis; Features of observational studies increasing validity; Factors complicating morbidity comparisons of hemodialysis and peritoneal dialysis.

  • Peritonitis and catheter exit-site infection in patients on peritoneal dialysis at home. Cristina Freire Abud, Ana; Kusumota, Luciana; Lúcia Zanetti, Maria; Antônio dos Santos, Manoel; Fernanda Luchetti Rodrigues, Flávia; Maria Coelho Damasceno, Marta // Revista Latino-Americana de Enfermagem (RLAE);Sep/Oct2015, Vol. 23 Issue 5, p902 

    Objective: to analyze the complications related to peritonitis and catheter exit-site infections, in patients on peritoneal dialysis at home. Method: quantitative and cross-sectional study, carried out with 90 patients on peritoneal dialysis at home, in a municipality in the Northeast region of...

  • Sirolimus/prednisone.  // Reactions Weekly;11/22/2008, Issue 1229, p26 

    The article describes the case of an elderly female renal transplant recipient who developed persistent peritoneal dialysis catheter exit-site leak during immunosuppressive treatment with sirolimus and prednisone. A brief overview of the patient's medical history is presented. The dosage of the...

  • Vancomycin.  // Reactions Weekly;4/7/2012, Issue 1396, p40 

    The article describes the case of a 34-year-old man on peritoneal dialysis (PD) who developed chemical peritonitis while receiving treatment with intraperitoneal vancomycin.

  • Surgical Management of Peritoneal Dialysis Peritonitis: The Impact of Peritoneal Sclerosis. Mavor, Eli // World Journal of Surgery;Jul2009, Vol. 33 Issue 7, p1395 

    The article focuses on managing peritonitis, a surgical complication of peritoneal dialysis (PD). It outlines the nature of peritonitis which is a result to the contamination of the pathogenic skin bacteria, and relates that most of the peritonitis measures have failed to assess the disease. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics